Reported Settlement Leads To Administrative Closure Of Novo Nordisk Insulin Pen Suit
NEW HAVEN, Conn. — Following a reported settlement, a Connecticut federal judge in a Nov. 12 docket entry administratively closed a hospital system’s suit alleging that Novo Nordisk Inc. failed to...To view the full article, register now.
Already a subscriber? Click here to view full article